Adil Javed

Adil Javed practices at The University of Chicago Medical Center in Chicago, Illinois.

Adil Javed's NPI, 1932142833, was assigned on June 14, 2006. Adil Javed graduated from Southern Illinois University School of Medicine in 2000. Adil Javed holds Illinois license 036109670.

Adil Javed's primary practice is The University of Chicago Medical Center, at 5841 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Adil Javed's primary practice is The University of Chicago Medical Center in Chicago, Illinois. Adil Javed is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Adil Javed to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Adil Javed practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Adil Javed's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Adil Javed is licensed in Illinois.

CMS data shows 314 Medicare services from Adil Javed across 3 procedure codes in 2024, all of them office visits, for 245 Medicare patients. Medicare paid $26,535 for them.

CMS counts 245 Medicare patients who saw Adil Javed in 2024. The largest group is 65 to 74, with 110 patients. 69% of them have high blood pressure, and 65% have high cholesterol. 45% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Adil Javed's median patient age at 60, with 72% women.

In 2024, Adil Javed wrote 2,751 Medicare Part D claims for 264 patients. 84% of them were for generic drugs. CMS names the drug for 2,457 of them, across 50 drugs with 11 or more claims each, at $4,014,879 in total drug cost. In 2023, CMS named 2,453 claims across 48 drugs.

Adil Javed accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Adil Javed as offering telehealth.

Dmand AI links 26 papers to Adil Javed, published from 2010 to 2025. 2018 was the busiest year, with 5. The most frequent topics are Magnetic Resonance Imaging, Multiple Sclerosis and Neuromyelitis Optica. Adil Javed has published most often in PLoS One. Adil Javed's most frequent co-authors are Anthony T. Reder, MD, Amanda Frisosky Abuaf, MD and Jacqueline Therese Bernard, MD.

CMS Open Payments shows 1,396 general payments to Adil Javed from 22 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Sanofi and Genzyme US Companies paid the most, $429,552. It also lists 1 research payment totaling $148 in 2023.

Adil Javed graduated from Southern Illinois University School of Medicine in 2000.